The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

The Quick Take
The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to MarketWatch.



